Chao‐Wei Hsu

Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B

Ching‐Lung Lai, Edward Gane, Yun‐Fan Liaw et al. · New England Journal of Medicine · 2007 · 775 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients

Wen‐Juei Jeng, I‐Shyan Sheen, Yi‐Cheng Chen et al. · Hepatology · 2013 · 223 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B

Kung‐Hao Liang, Chao‐Wei Hsu, Ming‐Ling Chang et al. · The Journal of Infectious Diseases · 2015 · 85 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Identification of a Hepatitis B Virus S Gene Mutant in Lamivudine-Treated Patients Experiencing HBsAg Seroclearance

Chao‐Wei Hsu, Chau‐Ting Yeh, Ming‐Ling Chang et al. · Gastroenterology · 2006 · 54 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +14

Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B

Chau‐Ting Yeh, Tiffany Chen, Chao‐Wei Hsu et al. · BMC Cancer · 2011 · 54 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +16